CD4 and central nervous system cancer: The analysis shows that in glioma patients who had high levels of IGFBP5 expression, the levels of T cell CD4+ memory cells, Neutrophil cells, B cell memory cells, Macrophages, Tregs, and NK cell resting cells significantly increased.